In Brief: Glaxo's Wellbutrin SR
This article was originally published in The Tan Sheet
Executive Summary
Glaxo's Wellbutrin SR: Bupropion sustained-release tablets recommended for approval as an Rx smoking cessation aid by FDA's Drug Abuse Advisory Committee on Dec. 12. The committee unanimously agreed that the antidepressant is safe and effective for the new indication...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning